Inhaled corticosteroids (ICS) have been used as first line treatment of asthma for many
decades. ICS are a form of exogenous glucocorticosteroids that can suppress the …

Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents available for
the treatment of asthma and represent the mainstay of therapy for most patients with the …

Objective: Adrenal insufficiency (AI) is a potentially life-threatening condition. It is known that
high doses of inhaled corticosteroids (ICS) can induce systemic adverse effects. Currently …

Objective: We aimed to estimate pooled percentages of patients with adrenal insufficiency
after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we …

Background Exposure to any form of glucocorticoid preparation is associated with a risk of
adrenal insufficiency (AI). Objective To establish the contribution of oral corticosteroid (OCS) …

Adrenal insufficiency is a potential complication of therapy with an inhaled corticosteroid
(ICS). Although prior studies found the highest risk of adrenal insufficiency with fluticasone, a …

Corticosteroids are the mainstay of treatment of all asthma severity levels in adults and
children. With their widespread use comes a responsibility to monitor, understand, and …

Background We previously reported that as many as one third of hospitalized patients with
asthma treated with a low to medium daily dose of inhaled steroids (ICSs) for an average of …

Background: Adrenal insufficiency, a well recognised complication of treatment with oral
corticosteroids, has been described in association with inhaled corticosteroid use in over 60 …

Glucocorticoids (GCs) are widely used due to their anti-inflammatory and
immunosuppressive effects. As many as 1–3% of the population are currently on GC …